RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity.
Duan X, Hu J, Zhang Y, Zhao X, Yang M, Sun T, Liu S, Chen X, Feng J, Li W, Yang Z, Zhang Y, Lin X, Liu D, Meng Y, Yang G, Lin Q, Zhang G, Lei H, Yi Z, Liu Y, Liang X, Wu Y, Diao W, Li Z, Liang H, Zhan M, Sun HW, Li XY, Lu L.
Duan X, et al. Among authors: yang g.
EMBO Mol Med. 2024 Sep 25. doi: 10.1038/s44321-024-00136-9. Online ahead of print.
EMBO Mol Med. 2024.
PMID: 39322862